Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
BACIL PHARMA LTD.
Bacil Pharma Ltd.
BSE: 524516
|
ASM
Download real time
48.47
-0.16
(
-0.33
%)
81.60% Gain from 52W Low
15,109
BSE Volume
BSE
25 Mar, 2026 3:31 PM (IST)
Watchlist
Portfolio
Alert
My Notes
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Bacil Pharma - BACPHAR, 524516 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Bacil Pharma
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Bacil Pharma Bonus history
Bacil Pharma has not announced any bonus since Jan 1, 2000.
See all forthcoming Bonus and Splits
Bacil Pharma Split history
Bacil Pharma has not split the face value of the share since Jan 1, 2000.
See all forthcoming Bonus and Splits
Bacil Pharma Dividend history
Bacil Pharma has not given any dividends since Jan 1, 2000.
See all forthcoming dividends
Board Meetings - Bacil Pharma
The latest board meeting for Bacil Pharma took place on 13 Feb 2026, for the purpose of Quarterly Results
Ex-Date
Purpose
Notes
13 Feb 2026
Quarterly Results
-
13 Nov 2025
Quarterly Results
-
05 Sep 2025
Others
Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters.
25 Aug 2025
Others
Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters.
12 Aug 2025
Quarterly Results
-
16 Jul 2025
Others
Inter-alia, to consider 1. Appointment of a new Executive Director and Chief Financial Officer of the Company. 2. Resignation of the present Chief Financial Officer. 3. Other business matters.
26 May 2025
Audited Results
-
21 Jan 2025
Quarterly Results
-
23 Oct 2024
Quarterly Results
-
15 Oct 2024
Others
-
See all Board Meetings for Bacil Pharma
Bacil Pharma Rights history
Bacil Pharma has not issued
any
rights since Jan 1, 2000.
See all Rights History for Bacil Pharma